· Updated · Venture Capital Tracker · investment-strategies  · 3 min read

Madison WI Startups and VC Firms in 2026: Exact Sciences, Fetch, gener8tor

Madison venture map in 2026 — Exact Sciences (NASDAQ: EXAS), Fetch, Understory, plus gener8tor HQ, HealthX Ventures, and Clarevia Ventures.

Madison WI Startups and VC Firms in 2026: Exact Sciences, Fetch, gener8tor

Madison is a biotech diagnostics and consumer tech university market — Exact Sciences (Cologuard) as the public flagship, Fetch as the consumer rewards scale-up, Understory in climate-risk — with gener8tor headquartered here (not Milwaukee), plus HealthX and Clarevia for healthcare seed.

This page maps what we profile.

City hub: /vc/madison-wi · All cities: /cities · Fund directory: /directory

What Madison is (and is not)

Madison is…Madison is not…
Home of gener8tor HQ and Exact Sciences (NASDAQ: EXAS)Milwaukee’s industrial/insurer map
UW–Madison commercialization + University Research Park densityA coastal multi-stage HQ substitute
HealthX + Clarevia (ex–Venture Investors) healthcare seedEmpty local fund coverage

Startups we cover in Madison

CompanyWhat they doStage / statusNotable capitalProfile
Exact SciencesMolecular diagnostics company behind Cologuard and broader cancer screening/therapy guidance tests.PublicNASDAQ:EXAS/startup/exact-sciences
FetchConsumer rewards app: scan receipts / shop to earn gift cards; sells brand insights.GrowthHQ: 1050 E Washington Ave, 2nd Floor, Madison, WI 53703/startup/fetch-rewards
UnderstoryClimate-risk insurance and hyperlocal weather risk platform for weather-exposed industries.Series AHQ: 4916 E Broadway, Suite 200, Madison, WI/startup/understory

Why these names matter

Exact Sciences — Madison’s flagship public diagnostics company (NASDAQ:EXAS) — corporate HQ 5505 Endeavor Lane, Madison, WI per SEC; major University Research Park presence.

Fetch — Madison consumer scale-up with HQ at 1050 East Washington Avenue — national rewards app born in Wisconsin.

Understory — Madison insurtech with proprietary weather sensing + Dealers Open Lot insurance; $15M Series A (Jun 2024) co-led by True Ventures and Prelude Ventures.

Local investors (Madison HQ or program)

FirmRoleStagesProfile
gener8torGlobal accelerator network — HQ Madison, WIPre-Seed, Seed/fund/gener8tor
HealthX VenturesMadison digital health seed (Mark Bakken)Pre-Seed, Seed/fund/healthx-ventures
Clarevia VenturesMidwest healthcare VC formerly Venture Investors Health FundSeed, Series A/fund/clarevia-ventures

How to read this: gener8tor HQ is Madison — common lore placing it in Milwaukee is wrong in our data. Clarevia is the rebrand of Venture Investors Health Fund.

National capital Madison founders still need

Local funds rarely replace a coastal or specialist Series A. Pitch these directory firms by thesis, not geography:

FirmWhy founders careProfile
Andreessen HorowitzConsumer / multi-stage when metrics clear/fund/andreessen-horowitz
Define VenturesDigital health specialist/fund/define-ventures
F-Prime CapitalDiagnostics / life sciences adjacency/fund/f-prime-capital
Bessemer Venture PartnersCloud/consumer growth patterns/fund/bessemer-venture-partners
General CatalystMulti-stage health + consumer/fund/general-catalyst

Madison seed vs national growth — what differs

gener8tor / HealthX / ClareviaNational Series A+
Best forAccelerator formation, digital health seedDiagnostics or consumer growth rounds
Check shapeAccelerator + healthcare seedMulti-stage / specialist priced rounds
UnderwriteWisconsin HQ + UW talentNational category leadership
MistakeAssuming gener8tor HQ is MilwaukeePitching Exact Sciences as a seed-stage peer

Worked example (illustrative)

Setup: A Madison digital-health startup completes gener8tor or HealthX seed and lands UW Health or regional system pilots.

Move: They raise a $20M+ Series A from Define / F-Prime–class capital.

Punch: Madison clinical adjacency proved the product; national health capital priced the round.

When Madison is the wrong capital market

  • You need Rockwell/industrial Milwaukee density — use /vc/milwaukee.
  • You treat Exact Sciences as a private seed-stage startup.
  • You cite Venture Investors without the Clarevia rebrand.
  • You invent Madison multi-stage HQ funds beyond the three we list.

How to use this page

  1. Read Exact Sciences, Fetch, Understory.
  2. Local: gener8tor, HealthX, Clarevia.
  3. Live hub: /vc/madison-wi.
  4. Compare: Milwaukee startups & VC 2026.

Sources

  1. Startup profiles: exact-sciences, fetch-rewards, understory
  2. Fund profiles: gener8tor, healthx-ventures, clarevia-ventures

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »

Nua’s $50M Series C Mixes Primary and Secondary — No Split, No Valuation

Peak XV and Filter Capital led a $50 million (~₹472 crore) Series C for Mumbai women’s-wellness brand Nua on September 7, 2026. The company said the print mixes primary capital and secondaries. Inc42 had reported $20–25 million talks. Valuation was not disclosed. ₹500 crore annualised run rate is a company claim.